New York, NY · Founded 2016 · Privately Held (backing)
Developer of an implantable stent-rode designed to create a brain-computer interface. Synchron is based in New York, NY and was founded in 2016. It was valued at $385 million at its later-stage round in Dec 2022, the last priced event on record. It has raised $340 million across 1 recorded round; the latest was a $49.9 million early-stage round in Nov 2022.
PMV mark · valuation
$385.0M
Oct 2026
Priced at
its later-stage round
Dec 2022
Total raised
$339.9M
Last round
Early Stage VC
Nov 2022
Team — not yet on record
No current team members for Synchron are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Synchron with a free account
·The complete investor list: 47 names
·Watch Synchron: the Monday email on marks, rounds and moves
